Pirenoxine

DB15945InvestigationalSmall molecule

Pirenoxine is a medication indicated to treat cataracts.

Chemical structure of Pirenoxine
Formula / weight
C16H8N2O5 · 308.249 g/mol (avg)
Code names
213-872-4

Resolves to

Compound
UNII27L0EP6IZKCAS1043-21-6ChEMBLCHEMBL1372341ChEBI32013
Clinical / RWD
RxNorm228080
Structure
InChIKeyOKPNYGAWTYOBFZ-UHFFFAOYSA-NSMILESOC(=O)C1=NC2=C(C(O)=C1)C1=NC3=CC=CC=C3OC1=CC2=O

What you can answer from here — as of August 30, 2026

3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
7Marketed productsAcross 4 countries and 7 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Pirenoxine, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In